Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Flutamide reduces hair growth better but has more side effects.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Hidradenitis suppurativa improves with antiandrogen therapy.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Minoxidil effectively controls blood pressure but side effects may limit its use.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

New acne treatments show promise as alternatives to traditional therapies.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.